RCKT Gaurav Shah sold ROCKET PHARMACEUTICALS, INC. shares — SEC Form 4SELLROCKET PHARMACEUTICALS, INC.

Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 9,650 shares at $18.50 ($179K) on 2024-08-16, disclosed to the SEC on 2024-08-20.

SEC EDGAR Filing

0001140361-24-037932

View on SEC EDGAR

Trade context

Open-market sale of $179k RCKT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.

Modest57/100

Nothing distinguishes this filing.

Opportunistic Sell

Trade Context

•Decreased holdings by 1%
•Last sale was 92 days ago
•4 other insiders also sold in last 30 days
•Stock down -37% in previous 6 months

Filing Info

Filed2024-08-20

Traded2024-08-16

Accession0001140361-24-037932

SourceSEC EDGAR (Historical)

Insider

NameGaurav Shah

TitleCEO

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
RCKT	SELL	2026-08-20	$8K	—	Filing →
RCKT	SELL	2026-08-17	$10K	—

Get an email when an insider at RCKT files

Free account. Follow RCKT and up to 10 more companies.

Follow RCKT for free

RCKT Gaurav Shah sold ROCKET PHARMACEUTICALS, INC. shares — SEC Form 4SELLROCKET PHARMACEUTICALS, INC.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes